IgG4-related disease presenting with recurrent abdominal pain: a long way until the diagnosis

Ana Petkovic¹, Maja Stojanovic^{2

3}, Sanvila Raskovic^{2

3}, Aleksandra Plavsic^{2

3}, Rada Miskovic^{4

5}

Affiliations

¹ Department of Radiology, Center of Stereotaxic Radiosurgery, Clinic of Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia.
² Clinic of Allergy and Immunology, University Clinical Center of Serbia, Belgrade, Serbia.
³ Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
⁴ Clinic of Allergy and Immunology, University Clinical Center of Serbia, Belgrade, Serbia. rada_delic@hotmail.com.
⁵ Faculty of Medicine, University of Belgrade, Belgrade, Serbia. rada_delic@hotmail.com.

Ana Petkovic et al. Intern Emerg Med. 2023 Aug.

. 2023 Aug;18(5):1591-1593.

doi: 10.1007/s11739-023-03300-0. Epub 2023 May 11.

Ana Petkovic¹, Maja Stojanovic^{2

3}, Sanvila Raskovic^{2

3}, Aleksandra Plavsic^{2

3}, Rada Miskovic^{4

5}

¹ Department of Radiology, Center of Stereotaxic Radiosurgery, Clinic of Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia.
² Clinic of Allergy and Immunology, University Clinical Center of Serbia, Belgrade, Serbia.
³ Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
⁴ Clinic of Allergy and Immunology, University Clinical Center of Serbia, Belgrade, Serbia. rada_delic@hotmail.com.
⁵ Faculty of Medicine, University of Belgrade, Belgrade, Serbia. rada_delic@hotmail.com.

No abstract available

References

1. Wallace ZS, Naden RP, Chari S et al (2020) The 2019 American College of Rheumatology/European league against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis 79:77–87. https://doi.org/10.1136/ANNRHEUMDIS-2019-216561 - DOI - PubMed
1. Lanzillotta M, Lanzillotta M, Mancuso G et al (2020) Advances in the diagnosis and management of IgG4 related disease. BMJ. https://doi.org/10.1136/BMJ.M1067 - DOI - PubMed
1. Fernández-Codina A, Pinilla B, Pinal-Fernández I et al (2018) Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index. Jt Bone Spine 85:721–726. https://doi.org/10.1016/j.jbspin.2018.01.014 - DOI
1. Khosroshahi A, Wallace ZS, Crowe JL et al (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67:1688–1699. https://doi.org/10.1002/ART.39132 - DOI - PubMed
1. Ebbo M, Grados A, Samson M et al (2017) Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients. PLoS One. https://doi.org/10.1371/JOURNAL.PONE.0183844 - DOI - PubMed - PMC